Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn R Webster

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Expert Opinion on Investigational Drugs|October 17, 2006
Fentanyl buccal tabletsLynn R Webster
Pain Medicine (Malden, Mass.)|May 14, 2013
A responsible way to treat patients and painLynn R Webster
Expert Opinion on Investigational Drugs|August 10, 2007
Oxytrex: an oxycodone and ultra-low-dose naltrexone formulationLynn R Webster
The American Journal of Managed Care|July 22, 2008
Breakthrough pain in the management of chronic persistent pain syndromesLynn R Webster
Pain Medicine (Malden, Mass.)|October 14, 2015
Opioid-Induced ConstipationLynn R Webster
Anesthesiology Clinics|May 22, 2016
Chronic Pain and the Opioid ConundrumLynn R Webster
The New England Journal of Medicine|July 14, 2016
Mitigation Strategies for Opioid AbuseLynn R Webster
Pain Medicine (Malden, Mass.)|November 19, 2013
New policing role for pharmacists undermines partnership with prescribersLynn R Webster
The New England Journal of Medicine|February 18, 2011
Opioids and deathsLynn R Webster
Expert Opinion on Investigational Drugs|February 17, 2007
PTI-821: sustained-release oxycodone using gel-cap technologyLynn R Webster
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Expert Opinion on Investigational Drugs|October 17, 2006
Fentanyl buccal tabletsLynn R Webster
Pain Medicine (Malden, Mass.)|May 14, 2013
A responsible way to treat patients and painLynn R Webster
Expert Opinion on Investigational Drugs|August 10, 2007
Oxytrex: an oxycodone and ultra-low-dose naltrexone formulationLynn R Webster
The American Journal of Managed Care|July 22, 2008
Breakthrough pain in the management of chronic persistent pain syndromesLynn R Webster
Pain Medicine (Malden, Mass.)|October 14, 2015
Opioid-Induced ConstipationLynn R Webster
Anesthesiology Clinics|May 22, 2016
Chronic Pain and the Opioid ConundrumLynn R Webster
The New England Journal of Medicine|July 14, 2016
Mitigation Strategies for Opioid AbuseLynn R Webster
Pain Medicine (Malden, Mass.)|November 19, 2013
New policing role for pharmacists undermines partnership with prescribersLynn R Webster
The New England Journal of Medicine|February 18, 2011
Opioids and deathsLynn R Webster
Expert Opinion on Investigational Drugs|February 17, 2007
PTI-821: sustained-release oxycodone using gel-cap technologyLynn R Webster
Pageof 14